๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis

โœ Scribed by Michael P. Malter; Christoph Helmstaedter; Horst Urbach; Angela Vincent; Christian G. Bien


Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
355 KB
Volume
67
Category
Article
ISSN
0364-5134

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Antibodies to Glutamic Acid Decarboxylas
โœ Fukui, M.; Nakano, K.; Shigeta, H.; Yoshimori, K.; Fujii, M.; Kitagawa, Y.; Mori ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 124 KB ๐Ÿ‘ 1 views

Some patients with non-insulin-dependent (Type 2) diabetes mellitus (NIDDM) are positive for antibodies to glutamic acid decarboxylase (anti-GAD), which have been shown to be a useful marker for the diagnosis and prediction of insulin-dependent (Type 1) diabetes mellitus (IDDM). Anti-GAD positive NI

Elimination of islet cell antibodies and
โœ W. O. Richter; M. G. Donner; P. Schwandt ๐Ÿ“‚ Article ๐Ÿ“… 1997 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 69 KB ๐Ÿ‘ 2 views

Islet cell antibodies and glutamic acid decarboxylase II (GAD II) antibodies have been discussed in the autoimmune pathogenesis of insulin-dependent diabetes mellitus (IDDM). Hence, immunosuppressants, intravenous immunoglobulins, and plasmapheresis have been used in an effort to modulate autoimmune